Although genes JPD2, ALOX5, and KPNB1 have demonstrated significant potential in basic research - potentially playing crucial roles in early diagnosis, prognostic evaluation, treatment response monitoring for cancer, immune and inflammatory diseases, and serving as key targets for precision therapy - their mechanistic roles in depression warrant further investigation. This evidence concerns the gene KPNB1 and depressive symptom measurement.